Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing-Reference-Cited by-同舟云学术

Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing

Published:2023-02 Issue:2 Volume:7 Page:100107
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Chiasakul Thita,Crowther Mark,Cuker Adam^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference58 articles.

1. National trends in ambulatory oral nticoagulant use;Barnes;Am J Med,2015

2. Trends in anticoagulant prescribing: a review of local policies in English primary care;Ho;BMC Health Serv Res,2020

3. Direct-acting oral anticoagulants and their reversal agents-an update;Kustos;Medicines (Basel),2019

4. Prothrombin complex concentrates: an update;Franchini;Blood Transfus,2010

5. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis;Piran;Blood Adv,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-07

2. Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative Physician;Current Anesthesiology Reports;2024-04-27

3. Effect of low- versus high-dose 4-factor prothrombin complex concentrate in factor Xa inhibitor–associated bleeding: A qualitative systematic review;American Journal of Health-System Pharmacy;2024-03-02

4. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage;Hospital Pharmacy;2024-02-16

5. Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal;Clinical and Applied Thrombosis/Hemostasis;2024-01